在澳大利亚被诊断患有结直肠癌的人群中使用多种药物:基于人口的队列研究
Benjamin Daniels1, Monica Tang2, Maria Aslam3
1Medicines Intelligence Research Program, School of Population Health, UNSW Sydney, Australia.
The oncologist
|December 9, 2025
概括
多药性,即使用多种药物,在结直肠癌 (CRC) 患者中很常见. 这种高患病率,特别是治疗后,表明可能会增加健康问题,并降低幸存者的生活质量.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
背景情况:
- 多药在癌症治疗中存在风险,随着疾病的发展轨迹而演变.
- 了解结肠直肠癌 (CRC) 的多药性对于管理患者的治疗结果至关重要.
研究的目的:
- 为了估计CRC患者的多药性患病率,根据疾病传播分层.
- 确定诊断时和诊断后与多药学相关的因素.
主要方法:
- 澳大利亚新南威尔士州19056名CRC患者的回顾性队列研究 (2013-2017年).
- 定义的多药性是每年90天的季度同时服用≥5种非抗菌药物.
- 后勤回归分析了多药和患者因素之间的关联.
主要成果:
- 74%-79%的CRC患者经历过多种药物治疗;近50%的患者在诊断后2-5年经历过多种药物治疗.
- 与年龄 (≥70),女性性别,并发症,结肠癌和社会经济劣势相关的多药性可能性增加.
- 患病率因诊断时的疾病传播而异.
结论:
- 多药在澳大利亚CRC患者中非常普遍.
- 治疗后的高发病率表明过度的发病率和潜在的生存者的生活质量受损.
- 解决了在幸存者护理中需要药物管理策略的需求.
相关概念视频
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Cancer Prevention
7.6K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
7.6K
Drug Dosing: Geriatric Patients
212
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
212
Factors Influencing Drug Absorption: Disease States and Pharmacology
1.3K
Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
1.3K
Drugs for Treatment of Ulcerative Colitis in IBD
431
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
431
Combined Effects of Drugs: Synergism
6.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.7K


